Security key
03828A101
KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (APLT)
CUSIP: 03828A101
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 93,958,967
- Total 13F value
- $638,614,949
- Share change
- +32,508,735
- Put/Call ratio
- 4%
- SEC-reported price per share
- $6.80
- Number of holders
- 88
- Value change
- +$241,302,453
- Number of buys
- 62
- Number of sells
- 41
- Shares outstanding
- 143,223,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
88
Top holders
10
APLT full security history
Ownership snapshot
Full 13F holder table
KalVista Pharmaceuticals, Inc. SEC filings
KalVista Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of APLT - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRANKLIN RESOURCES INC
Disclosed value leader
FRANKLIN RESOURCES INC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 4.9%
Showing 1-6 of 15 holder rows.
Quick read
FRANKLIN RESOURCES INC leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRANKLIN RESOURCES INC's linked filing trail.
Comparable ownership
Top 5
FRANKLIN RESOURCES INC
4.9%
Venrock Adviser, LLC
4.4%
Knoll Capital Management, LLC
3.8%
Propel Bio Management, LLC
3.8%
Vestal Point Capital, LP
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC |
13F
Company
|
4.9%
|
$23,510,005
7,017,912 shares
|
— | 31 Dec 2023 |
| Venrock Adviser, LLC |
13F
Company
|
4.4%
|
$20,937,500
6,250,000 shares
|
— | 31 Dec 2023 |
| Knoll Capital Management, LLC |
13F
Company
|
3.8%
|
$18,340,201
5,474,687 shares
|
— | 31 Dec 2023 |
| Propel Bio Management, LLC |
13F
Company
|
3.8%
|
$18,006,190
5,374,982 shares
|
— | 31 Dec 2023 |
| Vestal Point Capital, LP |
13F
Company
|
2.9%
|
$13,919,250
4,155,000 shares
|
— | 31 Dec 2023 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
2.8%
|
$13,668,834
4,080,249 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
88
Shares
93,958,967
Rows available
88
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
88
Q1 2024 holders
88
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|